Back to Search
Start Over
Polydatin attenuates diabetic renal inflammatory fibrosis via the inhibition of STING pathway.
- Source :
-
Biochemical pharmacology [Biochem Pharmacol] 2024 Aug; Vol. 226, pp. 116373. Date of Electronic Publication: 2024 Jun 15. - Publication Year :
- 2024
-
Abstract
- Diabetic nephropathy (DN) is a complication of diabetes and is mainly characterized by renal fibrosis, which could be attributed to chronic kidney inflammation. Stimulator of interferon genes (STING), a linker between immunity and metabolism, could ameliorate various metabolic and inflammatory diseases. However, the regulatory role of STING in DN remains largely unexplored. In this study, knockdown of STING decreased extracellular matrix (ECM), pro-inflammatory, and fibrotic factors in high glucose (HG)-induced glomerular mesangial cells (GMCs), whereas overexpression of STING triggered the inflammatory fibrosis process, suggesting that STING was a potential target for DN. Polydatin (PD) is a glucoside of resveratrol and has been reported to ameliorate DN by inhibiting inflammatory responses. Nevertheless, whether PD improved DN via STING remains unclear. Here, transcriptomic profiling implied that the STING/NF-κB pathway might be an important target for PD. We further found that PD decreased the protein expression of STING, and subsequently suppressed the activation of downstream targets including TBK1 phosphorylation and NF-κB nuclear translocation, and eventually inhibited the production of ECM, pro-inflammatory and fibrotic factors in HG-induced GMCs. Notably, results of molecular docking, molecular dynamic simulations, surface plasmon resonance, cellular thermal shift assay and Co-immunoprecipitation assay indicated that PD directly bound to STING and restored the declined proteasome-mediated degradation of STING induced by HG. In diabetic mice, PD also inhibited the STING pathway and improved the pathological changes of renal inflammatory fibrosis. Our study elucidated the regulatory role of STING in DN, and the novel mechanism of PD treating DN via inhibiting STING expression.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Subjects :
- Animals
Mice
Male
Signal Transduction drug effects
Mesangial Cells drug effects
Mesangial Cells metabolism
Mesangial Cells pathology
Humans
Glucosides pharmacology
Glucosides therapeutic use
Diabetic Nephropathies metabolism
Diabetic Nephropathies drug therapy
Diabetic Nephropathies pathology
Membrane Proteins metabolism
Membrane Proteins genetics
Fibrosis drug therapy
Stilbenes pharmacology
Stilbenes therapeutic use
Mice, Inbred C57BL
Diabetes Mellitus, Experimental drug therapy
Diabetes Mellitus, Experimental metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1873-2968
- Volume :
- 226
- Database :
- MEDLINE
- Journal :
- Biochemical pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 38885772
- Full Text :
- https://doi.org/10.1016/j.bcp.2024.116373